Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 226

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 226
---
 our common shares as Commitment Shares upon execution of the SEPA. In addition, we have paid the Selling Shareholder a structuring fee of $25,000.

We also have agreed to indemnify the Selling Shareholderand certain otherpersons against certain liabilitiesin connection with theoffering of our common shares offered hereby, including liabilities arising under the Securities Act, or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. The Selling Shareholder has agreed to indemnify us against liabilities under the Securities Act that may arise from certain written information furnished to us by the Selling Shareholder specifically for use in this prospectus or, if such indemnity is unavailable, to contribute certain amounts required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that, in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

The Selling Shareholder has represented to us that at no time during the period commencing as of the time that the Selling Shareholder first contacted the Company regarding the specific investment in the Company contemplated by the SEPA and ending immediately prior to the execution of the SEPA has the Selling Shareholder engaged, directly or indirectly, any transactions with respect to our common shares, including any short sale or any transaction that establishes a net short position. The Selling Shareholder has agreed that, during the term of the SEPA, none of the Selling Shareholder, its officers or any entity managed or controlled by the Selling Shareholder will enter into or effect, directly or indirectly, any short sale or any transaction that establishes a net short position with respect to our common shares for its own account or for the account of any other such person or entity; provided, the foregoing shall not prohibit the Selling Shareholder from selling "long" anyof our common sharesor selling a numberof our common sharesequal to a number of ourcommon shares tobe issued pursuant to an Advance Notice, following receipt of such Advance Notice, but prior to receiving such shares.

We have advised the SellingShareholderthatit isrequired to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes the SellingShareholder,any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or purchasing, or attempting to induce any person to bid for